| The medical management of epilepsy. | |
| | |
MedLine Citation:
|
PMID: 22146419 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
With many new medications on the market and new data about the various side-effects of antiepilepsy drugs (AEDs), the medical management of epilepsy can seem unnecessarily complicated for the non-specialist. The process can be thought of taking place in 7 steps: 1) assessing the need for medications; 2) defining the seizures and classifying the epilepsy syndrome; 3) knowing which medications are best used in which syndromes; 4) taking into account patient priorities when choosing a medication, such as cotreatment or avoidance of neurobehavioral issues and weight loss or gain; 5) considering other life issues, such as planning a pregnancy and breastfeeding; 6) choosing a maintenance dose and deciding when to consider a change to another medication or to use dual therapy; and 7) if seizure-free, which patients to consider AED reduction or withdrawal. The goal is simply, no seizures and no side-effects. Seizure freedom is an important goal to reduce injury, mortality and improve quality of life. Improving tolerability is equally as important, as both acute and chronic side-effects of AEDs can be as disabling as seizures themselves. |
| | |
Authors:
|
D J Chong |
Related Documents
:
|
9133769 - The use of prn and stat medication in three child psychiatric inpatient settings. 16040229 - Guidelines for the use of clozapine in individuals with developmental disabilities. 6117579 - The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated pa... 19102669 - Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the ... 15990509 - Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and ob... 14982339 - "medication". 2707589 - Occupational therapy program development for medical-psychiatry units: a cognitive model. 14598399 - In vitro cytotoxicity testing of ab-polymer networks based on oligo(epsilon-caprolacton... 20050469 - The risks associated with consumer magazines giving advice on complementary therapies. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Panminerva medica Volume: 53 ISSN: 1827-1898 ISO Abbreviation: Panminerva Med Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0421110 Medline TA: Panminerva Med Country: Italy |
Other Details:
|
Languages: eng Pagination: 217-26 Citation Subset: IM |
Affiliation:
|
Division of Epilepsy and Sleep, Department of Clinical Neurology, Columbia University Medical Center, New York, NY, USA - dc2223@columbia.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epilepsy and celiac disease: review of literature.
Next Document: Surgical successes and failures of invasive video-EEG monitoring in the presurgical evaluation of ep...